The Institute for Innovation in Imaging (i3) core provides guidance and access to unique resources that enable translation of promising imaging technology or innovative imaging experiments.
MISSION
1) Enable translation of promising imaging technologies. 2) Provide access to unique equipment, technology and expertise to perform research not otherwise possible.
CORE FOCUS Fibrosis | Inflammation | Pharmacology
SERVICES
Translational Project Management - Consulting for development, evaluation, creation and submission of Food and Drug Administration (FDA) Investigational New Drugs (IND).
Translation - Creation and management of Investigational New Drugs (IND) and Institutional Review Board (IRB) applications for first in human trials.
Clinical Research - Management of human subjects for early phase clinical trials.
Liquid Chromatography Mass Spectrometry - Liquid Chromatography / Mass Spectrometry (LC/MS) sample analysis.
Elemental Analysis - Metal analysis in chemical or biological samples.
Radiochemistry - Production of radiotracers for preclinical or clinical use, development of new radiotracers, and Chemistry, Manufacturing and Controls (CMC) optimization.
Fluorescence Microscopy - Highly adaptable, multimodal intravital and cellular imaging (Widefield, Total Internal Reflection Fluorescence (TIRF), Confocal, Multiphoton, Lifetime).
Preclinical Surgery - Small animal surgical procedures to assist in imaging experiments.
Tissue Culture - Cell and tissue culture for custom cell line generation and imaging experiment support.
GMP PET Probe Production (coming soon).
Please Contact Matt Dubach (dubach.matt@mgh.harvard.edu) for further information.
